PreveCeutical Medical Inc. (CSE:PREV)

Market Cap	16.31M
Revenue (ttm)	n/a
Net Income (ttm)	-1.36M
Shares Out	543.70M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	120,543
Open	0.0250
Previous Close	0.0250
Day's Range	0.0250 - 0.0250
52-Week Range	0.0150 - 0.0450
Beta	0.81
RSI	63.11
Earnings Date	Apr 25, 2025

About PreveCeutical Medical

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and o...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Stephen Van Deventer
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: PREV